Biomedical, Clinical & Life Sciences

HRSA HRSA-24-007: 2024 Rural Health Network Development Planning Program

 Limit: 1 // PIs: B. Eckert & D. Axon (College of Pharmacy)

 

In general, multiple applications associated with the same DUNS number and/or Employee Identification Number (EIN) are not allowable. However, HRSA recognizes a growing trend towards greater consolidation within the rural health care industry and the possibility that multiple health care organizations may share the same EIN as its parent organization. 

 

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year (FY) 2024 Rural Health Network Development Planning Program. The purpose of this program is to promote the planning and development of integrated health care networks to address the following legislative aims: (i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of basic health care services and associated health outcomes; and (iii) strengthen the rural health care system as a whole. 

Funding Type
Internal Deadline
External Deadline
01/26/2024

Lalor Foundation: 2024 Postdoctoral Fellowship Program in Reproductive Health - May Deadline

No Applicants // Limit: 1 // Tickets Available: 1 

 

The foundation will consider more than one application per institution per year, but only one application per laboratory/mentor per year.

The Lalor Foundation postdoctoral fellowship program supports promising new researchers in establishing scientific and teaching careers. The program’s mission is to support these researchers early in their work so that they can become independently funded in the field of mammalian reproductive biology as related to the regulation of fertility. The Lalor Foundation will award fellows $55,000 per year to cover a fellowship stipend, fringes, and institutional overhead. Other expenses are not allowed. Institutional overhead may not exceed 10 percent of the total fellowship award. Renewal for one additional year is possible; please refer to specific renewal information under Application Instructions. 

Funding Type
Internal Deadline
External Deadline
05/01/2024
Solicitation Type

G. Harold & Leila Y. Mathers Foundation: 2024 Basic & Translational Research Grants - Spring Cycle

 Limit: 4 //

M. Verhougstraete (Community, Environment & Policy)
J. Schroeder (Molecular and Cellular Biology)
H. Cai (Neuroscience)
J. Bibb (Translational Neurosciences)
 

The mission of The G. Harold and Leila Y. Mathers Foundation is to advance knowledge in the life sciences by sponsoring scientific research that will benefit mankind. The foundation’s grants program seeks to support basic science, ideally with potential translational applications. Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support. 

For many years the Foundation has enjoyed special recognition in the research community for supporting “basic” scientific research, realizing that true transformative breakthroughs usually occur after a thorough understanding of the fundamental mechanisms underlying natural phenomena. More recently, and with the advent of newer investigative methodologies, technology, and tools, the Foundation now embraces innovative translational research proposals.

The grant duration must be three years. The budget should be reasonable based on the aims of the project. Indirect costs may not exceed 10%. Preliminary Budgets are required during the LOI phase. A detailed budget justification is not required until the proposal phase.  The Foundation’s grant award is not intended to be utilized for purchasing capital equipment (“bricks-and-mortar”) for the lab and is intended only to support the actual investigation. The Foundation assumes and expects that capital equipment must be provided by the research institution or university.
 

Application Guidance:

  • Grant budgets cannot exceed $600-750K 
  • The Foundation primarily supports basic science, ideally with potential translational applications.
  • Immunology, microbiome, genomics, structural biology, cellular physiology, neuroscience, etc., are some noteworthy examples of current research support.
  • Covid-19-related research projects (aims or sub-aims) will not be considered for support.
  • Medical imaging technology-related projects and/or electrical engineering technology development projects will not be considered for support.
  • Plant Biology Research, Oceanography, Space Exploration. and Global warming-related research will not be considered for support.
  • As technology continues to advance, it is apparent that investigations in the area of basic science and translational research may become more and more reliant on collaborative, interdisciplinary projects. It is important to note that any interdisciplinary project proposals may require additional information regarding the collaborator(s)’ achievements and relevant expertise.
  • Feedback for declined LOI Requests will not be provided; LOIs or Formal Proposals that have been declined should not be resubmitted at a later date for consideration.
  • Renewal applications for the same or related research will not be accorded priority consideration. It is strongly advised that any re-application for grant renewal consider a new direction based on prior research or emphasize some new potential translational aspects and not merely an extension of previously funded research.
  • Requests for funding previously federally supported research and/or applications pending federal approval will not be accorded priority consideration.
  • Requests for support of clinical trials or drug discovery will not be approved. The Foundation will not support projects which we consider pre-clinical drug development.
Funding Type
Internal Deadline
External Deadline
03/08/20234- Required registration

HRSA HRSA-19-049, HRSA-24-033 : 2023 Healthy Start Initiative: Eliminating Disparities in Perinatal Health

No applicants  // Limit: 1 // Tickets Available: 1 

 

The Health Resources and Services Administration (HRSA) is accepting applications for fiscal year (FY) 2019 Healthy Start Initiative: Eliminating Disparities in Perinatal Health. The purpose of this Healthy Start (HS)program is to improve health outcomes before, during, and after pregnancy, and reduce racial/ethnic differences in rates of infant death and adverse perinatal outcomes. 

 

HS has two focus areas: 1) providing direct and enabling services (for example, screening and referrals, case management and care coordination, health and parenting education, and linkage to clinical care) to enrolled HS participants; and 2) convening Community Consortia (formerly known as Community Action Networks or “CANs”) comprised of diverse, multi-sector partners to advise and inform HS activities as well as to develop and implement plans to improve perinatal outcomes within the selected project area. HS continues to have an increased emphasis on addressing social determinants of health, such as access to adequate food, housing, and transportation, to improve disparities in maternal and infant health outcomes. Based on stakeholder feedback, this FY 2024 HS competition also provides recipients with increased flexibility to tailor interventions to the unique needs of their community and/or target population.

The goals of HS are to:

1) Continue reducing infant mortality rates in the United States, and

2) Decrease disparities in infant mortality and poor perinatal health outcomes in areas where those rates are high.

Funding Type
Internal Deadline
External Deadline
12/15/2023

ARPA-H 75N99224R00001: 2023 Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)

No Applicants  // Limit: 1 // Tickets Available: 1 

 

The APECx program aims to create a toolkit to enable accurate chimeric and broadly efficacious vaccine Ag discovery through predictive modeling, high-throughput functional experimentation, and protein engineering. To fundamentally transform the vaccine research and development (R&D) sector, APECx will develop an innovative viral Ag prediction pipeline for broad efficacy by combining expedited experimental protein structure and function determination with high-throughput Ag screening. This will be enhanced with structural and functional prediction and protein modeling algorithms. Product developers will contribute to modeling tool evaluation from the start of the program to ensure discoveries satisfy the translational requirements. The combined effort of all the teams will create a toolkit that will enable the U.S. to achieve genus-level vaccine goals and prevent multiple viral diseases, including those responsible for cancer, acute disease, and chronic illness across the country and the world. 

Funding Type
Internal Deadline
External Deadline
12/15/ 2023 - Abstract

NIH PAR-21-293: 2024 Clinical and Translational Science Award (UM1 Clinical Trial Optional)

Limit: 1 // PI: S. Radovick (Clinical and Translational Science Institute)

The CTSA Program hubs will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS) by developing, demonstrating, and disseminating scientific and operational innovations that improve the efficiency and effectiveness of clinical translation from identification to first-in-human studies to medical practice implementation to community health dissemination and promoting partnerships and collaborations to facilitate and accelerate translational research projects locally, regionally, and nationally.

Both a UM1 hub application and the required K12 Clinical Scientist Institutional Career Development Program Award (NOT-TR-21-030) must be submitted.

Funding Type
Internal Deadline
External Deadline
05/15/2024

2024 Packard Fellowships for Science and Engineering

 Limit: 2 // J.  Green (Environmental Science), L. Ikner (Environmental Science)

 

*Deadline note: Due to the competitive nature of this funding program, this selection process is running with an anticipated deadline.
We will inform all applicants of relevant updates in the guidelines, submission deadlines, and eligibility as soon as more information becomes available.

 

The Packard Fellowships for Science and Engineering Program invests in future leaders who can take risks, explore new frontiers in their fields of study, and follow uncharted paths that may lead to groundbreaking discoveries.

The Foundation established the Packard Fellowships for Science and Engineering to allow the nation's most promising early career professors to pursue their science and engineering research with few funding restrictions and limited paperwork requirements.

Competitive Proposals Will explain clearly in the nomination letter(s) why the investigator is creative, innovative and promising. The proposed research program has breakthrough potential and reflects that promise and a sense of adventure and creativity. Proposals should put the work and its significance in context of the larger field. And differentiates projects should be accessible to a group of very successful scientists from a diverse set of fields (i.e. stay away from field-specific jargon). Projects must have high impact referees that can emphasize the significance and impact of the “big idea” and how the fellowship will significantly impact the nominee’s career.

 

Eligibility:

  • Candidates must be faculty members who are eligible to serve as principal investigators engaged in research in the natural and physical sciences or engineering and must be within the first three years of their faculty careers.
  • Disciplines that will be considered include biology, chemistry, bio-medical engineering, physics, chemistry, mathematics, biology, astronomy, computer science, earth science, ocean science, and all branches of engineering. Candidates engaged in research in the social sciences will not be considered.
  • Candidates must be faculty members in the first three years of their faculty careers, that is, whose initial appointment began no earlier than May 31, 2021, and no later than May 31, 2024.
Funding Type
Internal Deadline
External Deadline
03/01/2024 (Nomination) - 04/10/2024 (Proposal)

U.S. Army Combat Capabilities Development Command (DEVCOM) Army Research Laboratory (ARL) Historically Black Colleges and Universities (HBCU)/Minority - Serving Institutions (MI) Early Career Program (ECP)

The DEVCOM Army Research Lab seeks unclassified research proposals from Historically Black Colleges and Universities and Minority-Serving Institutions (HBCU/MI) under Broad Agency Announcement (FOA) W911NF-23-S-0001-0002 (hereafter referred to as the DEVCOM ARL BAA”) to establish an Army HBCU/MI Early Career Program (ECP) which embodies the high priority placed by the government on maintaining the leadership position of the United States in science by producing outstanding scientists and engineers and nurturing their continued development. Each award will support basic research contributing to Army modernization needs conducted by outstanding scientists and engineers beginning their careers at HBCU/MI institutions. ECP awards are funded by the Army to support early career scientists and engineers who show exceptional ability and promise for conducting basic research. This targeted opportunity is open to U.S. citizens, U.S. Nationals, or Lawful Permanent Residents of the U.S. who have held a tenure- track position at a covered educational institution for fewer than five years at the time applications are due in response to this special notice. Faculty at an institution of higher education which does not designate a faculty appointment as "tenure track" are eligible if that fact is so indicated in the proposal, and the supporting letter from the institute states that the faculty member submitting the proposal will be considered for a permanent appointment, or it is demonstrated that the faculty member is within five years of receiving his or her first competitively awarded federal research funding (as principal investigator), excluding funds secured during graduate school or postdoctoral training/fellowship and funds secured for training, fellowship, education, or career development. The objective of the ECP Award is to foster creative basic research in science and engineering; enhance development of outstanding early career investigators; and increase opportunities for early career investigators to pursue research in areas relevant to the Army. Proposals that do not meet these criteria for the Principal Investigator (PI) will be considered ineligible and not reviewed or considered for funding.



The eleven DEVCOM ARL competencies are:

 Biological and Biotechnology Sciences

 Electromagnetic Spectrum Sciences

 Energy Sciences

 Humans in Complex Systems

 Mechanical Sciences

 Military Information Sciences

 Network, Cyber, and Computational Sciences

 Photonics, Electronics, and Quantum Sciences

 Sciences of Extreme Materials

 Terminal Effects

 Weapons Sciences

DEVCOM ARL plans to award up to eight (8) new HBCU/MI ECP grants at a total cost of $990,000 each over a duration of 5 years, with funding profile of $110,000 in year one, $165,000 in year two, $220,000 in year three, $330,000 in year four, and $165,000 in year five. Note this is more funding and longer duration than the typical ECP award specified in the DEVCOM ARL BAA.
Opportunity ID
d3bf1203-0df5-410a-946d-f2f1552f7976
External Deadline
01/25/2025 (Anticipated)

CDC RFA-DP-24-031: 2024 Epidemiologic Cohort Study of Interstitial Cystitis

No Applicants // Limit: 1 // Tickets Available: 1 

 

The purpose of this research NOFO is to follow a cohort of interstitial cystitis (IC) patients over time, define the demographic and clinical patterns of IC, and document its impact on the health of affected people. In addition, the focus of this NOFO will include translating the scientific knowledge on IC extracted from previously funded and other studies so it can be used to support public health action, including patient strategies for improving quality of life, provider awareness and education, and medical and self-management of IC; strengthen clinical, community, and public health linkages; and target groups disproportionately impacted by IC.

 

The estimated total funding (direct and indirect) for the first budget period (9/30/2024 to 9/29/2025) is $830,000. The estimated total funding (direct and indirect) for the entire performance period (9/30/2024 to 9/29/2029) is $4,150,000. The estimated award ceiling is $900,000 for the first 12-month budget period (9/30/2024 to 9/29/2025).

Funding Type
Internal Deadline
External Deadline
02/09/2024

NIH PAR-21-338: 2024 Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)

No applicants // Limit: 1 // Tickets Available: 1 

 

The National Center for Advancing Translational Sciences (NCATS) will award Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Institutional Research Training Grants for the Clinical and Translational Science Awards (CTSA) Program (T32) to eligible institutions to enhance postdoctoral research training of individuals with doctoral degrees (these include, but are not limited to, the following: D.M.D., DC, DO, DVM., OD, DPM, ScD, EngD, DrPH, DNSc, DPT, PharmD, ND [Doctor of Naturopathy], DSW, PsyD, as well as a doctoral degree in nursing research) and help ensure a heterogenous pool of clinical and translational scientists trainees are equipped with the knowledge, skills and abilities to advance diagnostics, therapeutics, clinical interventions, and behavioral modifications that improve health.

NCATS will not accept applications proposing combined predoctoral and postdoctoral training under this FOA. Applications proposing predoctoral research training should apply to the Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Institutional Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (PAR-21-337).

The proposed institutional research training program may complement other ongoing research training and career development programs at the applicant institution, but must be clearly distinct from related programs currently receiving Federal support.

 

This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial but does allow them to obtain research experience in a clinical trial on which the PI is a mentor or co-mentor.

NCATS solicits the submission of one set of companion applications. With this solicitation for the T32 application, a separate, companion FOA solicits applications for a required UM1 (PAR-21-293: Clinical and Translational Science Award). The UM1 and initial T32 applications must be submitted concurrently; a T32 application without the required companion UM1 application will not be reviewed. The T32 application will only be awarded if the UM1 application is awarded. Resubmission of a T32 without the required UM1 will be allowed only if the UM1 application is awarded.

The sponsoring institution must assure support for the proposed program. Appropriate institutional commitment to the program includes the provision of adequate staff, facilities, and educational resources that can contribute to the planned program.

 

Funding Type
Internal Deadline
External Deadline
01/12/2024